Profile
John Le Gall is currently Chief Medical Officer at Imugene Ltd., starting in 2026.
Formerly, Dr. Le Gall was Vice President & Head-Clinical Development at Allogene Therapeutics, Inc. from 2023 to 2026.
Education includes an MBA and a doctorate from The Trustees of Columbia University in The City of New York.
John Le Gall active positions
| Companies | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 2026-10-06 |
Former positions of John Le Gall
| Companies | Position | End |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-12-31 |
Education of John Le Gall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
- Stock Market
- Insiders
- John Le Gall
















